Nanoparticle Uptake in the Aging and Oncogenic

Maria Christou, Ayobami Fidelix, Yiorgos Apidianakis, Chrysafis Andreou

Abstract read

In one paragraph

Article in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Maria ChristouDepartment of Biological Sciences, University of Cyprus, Nicosia 2109, Cyprus.

Ayobami FidelixDepartment of Electrical and Computer Engineering, University of Cyprus, Nicosia 2109, Cyprus.ORCID 0009-0004-1745-7880

Yiorgos ApidianakisDepartment of Biological Sciences, University of Cyprus, Nicosia 2109, Cyprus.ORCID 0000-0002-7465-3560

Chrysafis AndreouDepartment of Electrical and Computer Engineering, University of Cyprus, Nicosia 2109, Cyprus.ORCID 0000-0002-3464-9110

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer remains a major global health concern. Colonoscopy, the gold-standard colorectal cancer diagnostic, relies on the visual detection of lesions and necessitates invasive biopsies for confirmation. Alternative diagnostic methods, based on nanomedicine, can facilitate early detection of malignancies. Here, we examine the uptake of surface-enhanced Raman scattering nanoparticles (SERS NPs) as a marker for intestinal tumor detection and imaging using an established

Indexed as

AgingDrosophila melanogasterNanoparticlesSpectrum Analysis, RamanAnimalsCarcinogenesisDrosophila melanogastergut diseasenanoparticle uptakeSERSsurface-enhanced Raman scattering

Identifiers

PMID39195234

DOI10.3390/cells13161344

PMCPMC11353203

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.